Ïîêðîâà ÀÌÏ Ëüâ³â"

Ïîêðîâà ÀÌÏ Ëüâ³â"

KYIV, UKRAINE - MAY 25, 2024 - Athletes play amputee football during a joint training session at Shakhtars training base in the Sviatoshynskyi district of Kyiv, capital of Ukraine. Players of FC Shakhtar Stalevi have welcomed members of FC Pokrova Lviv AMP and representatives of the team that trains with the support of the Ukrainian Association of Football.

Indonesia approves emergency use of China's mRNA COVID-19 vaccine

STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine DATELINE: Oct. 1, 2022 LENGTH: 0:01:17 LOCATION: Jakarta CATEGORY: HEALTH/MEDICINE SHOTLIST: 1. STANDUP (English): SUN LEI, Xinhua correspondent 2. various of press release 3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM) 4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 5. various of mRNA vaccine 6. various of BPOM STORYLINE: The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies. STANDUP (English): SUN LEI, Xinhua correspondent "The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose." AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog

Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots

STORY: Pfizer, Moderna seek FDA's authorization for second COVID-19 booster shots DATELINE: March 19, 2022 LENGTH: 00:02:36 LOCATION: Washington D.C. CATEGORY: HEALTH SHOTLIST: 1. various of the vaccine production line STORYLINE: American biotechnology company Moderna submitted a request to the U.S. Food and Drug Administration (FDA) on Thursday for emergency use authorization (EUA) on a fourth dose of its COVID-19 vaccine for adults 18 years of age and older, who already received a booster dose of any approved or authorized shot. The request to include adults over 18 years of age was made to provide flexibility for the U.S. Centers for Disease Control and Prevention and healthcare providers to "determine the appropriate use of an additional booster dose," including for those at higher risk of COVID-19 due to age or comorbidities, said the company in a statement. Currently a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level is authorized by the FDA for emergency use in the Unite